Comparative Study - Transseptal Suture Technique Verses Anterior Nasal Packing After Septoplasty

July 30, 2026 updated by: Ghazal Iftakhar

Trans Septal Suture Technique Verses Anterior Nasal Packing After Septoplasty - A Comparative Study

The goal of this clinical trial is to see the outcomes of the two techniques used after septoplasty in terms of postoperative nasal pain and nasal bleeding in the patients with deviated nasal septum of 18 to 50 years of age presented in a tertiary care hospital. The main questions it aims to answer are:

  1. any significant difference between the two techniques in terms of post operative nasal pain?
  2. any significant difference between the two techniques in terms of post operative nasal bleeding? Researchers will be comparing the outcomes of these two techniques while participants already admitted in ward will be examined on 1st postoperative day.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
    • Fedral
      • Islamabad, Fedral, Pakistan, 44080
        • Recruiting
        • Pakistan Institute of Medical Sciences (PIMS), Islamabad.
        • Contact:
          • Personal Assistant

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • symptomatic deviated nasal septum
  • 18-50 years of age
  • both male and female genders

Exclusion Criteria:

  • history of previous nasal surgery
  • presence of chronic rhinosinusitis with or without nasal polyposis
  • pregnant females
  • immunocompromised patients
  • patients with pulmonary and/or cardiovascular disorders
  • patients those who received steroidal or anticoagulant therapy within last 30 days.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group A = with anterior nasal packing postoperative septoplasty
Group A will consists of 30 participants which will have anterior nasal packing done postoperatively, after septoplasty.
Procedure: Anterior nasal packing
ANP
Active Comparator: Group B = with trans-septal suture technique
Group B will have 30 participants which will have trans-septal suture technique performed in septoplasty.
Procedure: Trans-septal suture technique
Trans-septal suture technique in septoplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post operative Nasal Pain
Time Frame: 24 hours after surgery on first post operative day
This will be assessed using Visual Analog scale on first post operative day
24 hours after surgery on first post operative day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post operative nasal hemorrhage
Time Frame: 24 hours after surgery on first post operative day
This will be assessed on first post operative day
24 hours after surgery on first post operative day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ghazal Iftakhar

Collaborators

Pakistan Institute of Medical Sciences

Investigators

  • Study Chair: Dr. Altaf Hussain, Pakisrtan Institute of Medical Sciences, Islamabad.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 14, 2026

Primary Completion (Estimated)

November 12, 2026

Study Completion (Estimated)

November 12, 2026

Study Registration Dates

First Submitted

July 30, 2026

First Submitted That Met QC Criteria

July 30, 2026

First Posted (Actual)

August 4, 2026

Study Record Updates

Last Update Posted (Actual)

August 4, 2026

Last Update Submitted That Met QC Criteria

July 30, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • No.F.1-1/2015/ERB/SZABMU/1428

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe